| Title: | Myocardial fibrosis and tissue alterations predict cardiovascular outcomes in chronic kidney disease - a prospective virtual twin study design using large-scale population database |
| Journal: | Frontiers in Cardiovascular Medicine |
| Published: | 11 May 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42199205/ |
| DOI: | https://doi.org/10.3389/fcvm.2026.1726445 |
| URL: | https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1726445/pdf |
Publication 20103
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Background: Myocardial fibrosis is a key feature of chronic kidney disease (CKD) and may contribute to its disproportionate cardiovascular (CV) burden. Cardiovascular magnetic resonance (CMR) T1-mapping quantifies diffuse fibrosis non-invasively, but its prognostic value in CKD remains uncertain.</p>
Aims: To investigate associations between native myocardial T1, mortality and incident CV outcomes, in CKD using a virtual twin-matching framework within the UK Biobank imaging cohort.</p>
Methods: We conducted a 1:1 virtual twin-matched case-cohort study of CKD cases and phenotypically matched non-CKD controls based on demographics, comorbidities, socioeconomic status, and cardiovascular risk factors. Paired analyses compared myocardial T1 between groups, and stratified Cox models estimated the effect of a 1-SD T1 increase on incident outcomes over a median follow-up of 4.9 years.</p>
Results: Among 193 matched pairs (median age 68 years; 57.5% women), CKD participants had trend-level higher myocardial T1 values than controls (p = 0.063), with greater differences among those experiencing adverse outcomes. Over follow-up, CKD participants had higher cumulative incidences of all-cause mortality (11.3 vs. 3.8 events/1,000 person-years; p = 0.049) and heart failure (12.7 vs. 3.9 events/1,000 person-years; p = 0.021). In CKD, each 1-SD increase in T1 was associated with higher risks of cardiovascular death (HR: 3.86; 95% CI: 1.62, 9.18), heart failure (HR: 2.00; 95% CI: 1.27, 3.15), and atrial fibrillation (HR: 2.04; 95% CI: 1.01, 4.12), but not all-cause mortality or myocardial infarction. No significant associations were observed in matched non-CKD controls.</p>
Conclusions: Elevated native myocardial T1 was independently associated with CV death, heart failure, and atrial fibrillation in CKD. Virtual twin-matching framework improved comparability and internal validity in matched pairs supporting the precision-matched cohort designs for mechanistic inference and risk stratification in multimorbid populations.</p>
8 Authors
- Georgios Vavilis
- Yeshe M. Kway
- Zahra Raisi-Estabragh
- Steffen E. Petersen
- Stefan Neubauer
- Qiang Zhang
- Vanessa M. Ferreira
- Stefan K. Piechnik
1 Application
| Application ID | Title |
|---|---|
| 59867 | Assessment of the heart-brain-liver-axis in the UK Biobank Imaging study |
Enabling scientific discoveries that improve human health